CA1010854A - Molecular inclusion compound of a silver alkanol ammine complex and cycloheptaamylose - Google Patents

Molecular inclusion compound of a silver alkanol ammine complex and cycloheptaamylose

Info

Publication number
CA1010854A
CA1010854A CA185,224A CA185224A CA1010854A CA 1010854 A CA1010854 A CA 1010854A CA 185224 A CA185224 A CA 185224A CA 1010854 A CA1010854 A CA 1010854A
Authority
CA
Canada
Prior art keywords
cycloheptaamylose
inclusion compound
ammine complex
molecular inclusion
alkanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA185,224A
Other languages
English (en)
Inventor
Andreas Hadhanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H TROMMSDORFF
Original Assignee
H TROMMSDORFF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H TROMMSDORFF filed Critical H TROMMSDORFF
Application granted granted Critical
Publication of CA1010854A publication Critical patent/CA1010854A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA185,224A 1972-12-11 1973-11-07 Molecular inclusion compound of a silver alkanol ammine complex and cycloheptaamylose Expired CA1010854A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2260536A DE2260536C3 (de) 1972-12-11 1972-12-11 MolekiileinschluBverbindungen aus einem Silberalkanolammin-Komplex und beta-Cycloheptaamylose, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CA1010854A true CA1010854A (en) 1977-05-24

Family

ID=5864075

Family Applications (1)

Application Number Title Priority Date Filing Date
CA185,224A Expired CA1010854A (en) 1972-12-11 1973-11-07 Molecular inclusion compound of a silver alkanol ammine complex and cycloheptaamylose

Country Status (14)

Country Link
US (1) US3911115A (id)
JP (1) JPS49133512A (id)
AT (1) AT317250B (id)
BE (1) BE808464A (id)
CA (1) CA1010854A (id)
CH (1) CH590880A5 (id)
DE (1) DE2260536C3 (id)
ES (1) ES421313A1 (id)
GB (1) GB1433828A (id)
HU (1) HU166786B (id)
NL (1) NL7316976A (id)
SE (1) SE409461B (id)
SU (1) SU520906A3 (id)
ZA (1) ZA738976B (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180183B (en) * 1980-12-19 1983-02-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing stable suppository compositions containing volatile and/or labile active substances
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
BE1004467A3 (nl) * 1990-06-18 1992-11-24 Sollie Philippe Stikstof- en zilverhoudend derivaat.
TW224049B (id) * 1991-12-31 1994-05-21 Sunkyong Ind Ltd
AU5153399A (en) 1998-08-14 2000-03-06 Coloplast A/S Stabilised compositions having antibacterial activity
US6027469A (en) * 1998-12-03 2000-02-22 Johnson; Lee D. Disinfecting system for hemodialysis apparatus
ATE282957T1 (de) * 2000-09-29 2004-12-15 Coloplast As Stabilisierte zusammensetzungen mit antibakterieller wirkung
US20030185889A1 (en) * 2002-03-27 2003-10-02 Jixiong Yan Colloidal nanosilver solution and method for making the same
US20040180093A1 (en) * 2003-03-12 2004-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US7285576B2 (en) 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US7745509B2 (en) 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US8399027B2 (en) 2005-04-14 2013-03-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US20070166399A1 (en) 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20100098949A1 (en) * 2006-10-18 2010-04-22 Burton Scott A Antimicrobial articles and method of manufacture
US8734876B2 (en) * 2009-12-29 2014-05-27 David A. French Confectionary product and method of manufacture and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923704A (en) * 1957-05-15 1960-02-02 Hoffmann La Roche Cycloamylose sulfates and derivatives thereof
US3122534A (en) * 1958-02-04 1964-02-25 Avebe Coop Verkoop Prod Amylose derivatives

Also Published As

Publication number Publication date
AU6307373A (en) 1975-06-05
BE808464A (fr) 1974-03-29
SE409461B (sv) 1979-08-20
GB1433828A (en) 1976-04-28
SU520906A3 (ru) 1976-07-05
AT317250B (de) 1974-08-26
DE2260536B2 (de) 1974-12-05
CH590880A5 (id) 1977-08-31
ZA738976B (en) 1974-11-27
HU166786B (id) 1975-05-28
DE2260536A1 (de) 1974-07-04
NL7316976A (id) 1974-06-13
ES421313A1 (es) 1976-04-16
US3911115A (en) 1975-10-07
DE2260536C3 (de) 1975-07-10
JPS49133512A (id) 1974-12-21

Similar Documents

Publication Publication Date Title
CA1003502A (en) Intravascular lead assembly
CA1010854A (en) Molecular inclusion compound of a silver alkanol ammine complex and cycloheptaamylose
CA1013675A (en) Cosmetic composition comprising a 1-hydroxy-2-pyridone
CA994180A (en) Continuous encapsulation
CA979229A (en) Turbocharger structure
CA991552A (en) Dictaphone
CA997739A (en) Pilable tape record and reel therefor
CA1023623A (en) Continuous encapsulation
CA983790A (en) Organo-metallic gold and silver solutions for electrostatic coating
CA1009974A (en) Des-lys29-ala30-insulin and production thereof
CA957150A (en) Telephone toy with phonograph
AU5482673A (en) Plastic-encapsulated variable-area flowmeter
AU499613B2 (en) Servo booster
AU5346873A (en) Butrophenone derivatives and production thereof
CA968113A (en) Telephone booth
AU477528B2 (en) Cycloheptaamyloe-silver alkanol ammine complex compound
CA914576A (en) Silver medicative
CA974239A (en) Metal-cobalt carbonyl complexes
CA898706A (en) Tape talking mechanism
AU470029B2 (en) Dipetide and production thereof
CA902398A (en) Transparency and sound track supporting assembly
AU491896B2 (en) Postage tape
CA899244A (en) Speech unscrambler
CA891766A (en) Nozzle and manifold assembly
CA914875A (en) Stairs and production thereof